verona pharma merck - Search News

Order byBest matchMost fresh

News

Merck eyes $10B buyout of Verona Pharma

· 2d · on MSN

Merck shells out $10 billion for Verona in bid to diversify beyond Keytruda

Merck said on Wednesday it will acquire UK-based Verona Pharma for about $10 billion, gaining a promising respiratory treatment as it faces pressure to diversify beyond its blockbuster cancer drug Keytruda.

Continue reading

· 2d · on MSN

Merck to Buy Verona Pharma in $10 Billion Deal

· 2d · on MSN

Verona Pharma Stock Soars to All-Time High as Merck Buys Firm for $10B

23h

Merck's Verona Acquisition: Plugging A $4B Hole In A $20B Gap

Merck’s recent acquisition announcement sends a strong signal regarding its urgency to tackle the impending Keytruda patent ...

2don MSN

Merck spends $10 billion for Verona, gaining access to its COPD medication

The deal gives Merck access to Verona Pharma’s new chronic obstructive pulmonary disease medication Ohtuvayre.

BioPharma Dive19h

With Verona deal, Merck wagers on strength of lung drug’s patents

The main patent for Ohtuvayre, the COPD drug at the heart of Verona’s $10 billion sale, expired in 2020. For Merck to make ...

3don MSN

Merck nears about $10 billion deal for London-based lung therapy firm Verona, FT reports

U.S. drugmaker Merck is nearing a deal worth about $10 billion to buy Verona Pharma, a company focused on therapies for lung ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results